Overview SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research Status: Recruiting Trial end date: 2022-11-30 Target enrollment: Participant gender: Summary This study is ongoing to evaluate the efficacy and safety of SHR-1209 in patients with hypercholesterolemia. Phase: Phase 3 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.